FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

34793911000001104: Ponatinib 30mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105524201000001116 Ponatinib 30mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105524301000001113 Ponatinib 30mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ponatinib 30mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet Has VMP Ponatinib 30mg tablets true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet Has specific active ingredient Ponatinib hydrochloride true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ponatinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Is a True Ponatinib 30mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start